Submission Details
| 510(k) Number | K170951 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 31, 2017 |
| Decision Date | April 28, 2017 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K170951 is an FDA 510(k) clearance for the CardioCel 3D, a Intracardiac Patch Or Pledget, Biologically Derived (Class II — Special Controls, product code PSQ), submitted by Admedus Regen Pty, Ltd. (Malaga, AU). The FDA issued a Cleared decision on April 28, 2017, 28 days after receiving the submission on March 31, 2017. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.3470.
| 510(k) Number | K170951 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 31, 2017 |
| Decision Date | April 28, 2017 |
| Days to Decision | 28 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | PSQ — Intracardiac Patch Or Pledget, Biologically Derived |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.3470 |
| Definition | To Repair Defects, To Be Used For Patch Grafting, To Repair Tissue, And To Buttress Sutures In The Heart And Vasculature. |